Coro Global Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-12-26: Form 8-K; Period of report 2013-12-19; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders; Details 1.01.
- 2013-08-14: Form 8-K; Period of report 2013-08-12; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2013-04-18: Form 8-K; Period of report 2013-04-14; Description 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; Details 1.01.
- 2013-02-06: Form 8-K; Period of report 2013-01-20; Description 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2013-12-26 | 8-K | 2013-12-19 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders | 1.01 On December 23, 2013, MedeFile International, Inc. (the “Company”) entered into and closed a securities purchase agreement with accredited investors (the “Investors”) pursuant to which the Company sold an aggregate of 17,000,000 shares of common stock for an aggregate purchase price of $340,000. 5.03 On December 19, 2013, Lyle Hauser, the majority stockholder of the Company, approved by written consent an amendment to the Company’s articles of incorporation to increase the number of authorized shares of the Company’s common stock from 100,000,000 to 500,000,000. | form8k.htm |
| 2013-08-14 | 8-K | 2013-08-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Arrangements of Certain Officers. | form8k.htm |
| 2013-04-18 | 8-K | 2013-04-14 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 On April 14, 2013, MedeFile International, Inc. (the “Company”) entered into and closed a securities purchase agreement with an accredited investor (the “Investor”) pursuant to which the Company sold 2,000,000 shares of common stock for a purchase price of $400,000. | form8k.htm |
| 2013-02-06 | 8-K | 2013-01-20 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 On January 20, 2013, MedeFile International, Inc. (the “Company”) entered into and closed a securities purchase agreement with an accredited investor (the “Investor”) pursuant to which the Company sold 400,000 shares of common stock for a purchase price of $200,000. | form8k.htm |